Jaguar Health, Inc. Stock Analysis & AI Score
Jaguar Health, Inc. (JAGX) has an ST Score of 29.9 (C-), driven by its Growth (B) and held back by its Financial Strength (F). Analysts rate it Buy with a $3.21 price target (+22.1% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
AI Daily Briefing
Analysis by AIJAGX Stock Price History
JAGX Technical Indicators
FMPEarnings Surprises
Analyst Forecast
Revenue Mix
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Analyst Price Target
ESG Score
JAGX Latest Stock News
ST Score
Jaguar Health, Inc. (JAGX) has an ST Score of 29.9 (C-), driven by its Growth (B) and held back by its Financial Strength (F). Analysts rate it Buy with a $3.21 price target (+22.1% upside).
- Strongest
- GrowthB
- Weakest
- Financial StrengthF
All factor grades
- GrowthB
- ValuationC
- ProfitabilityC-
- ForecastD+
- MomentumD
- Financial StrengthF
- Piotroski3/9
Press Releases
Company Contact Details
JAGX stock: frequently asked questions
What is JAGX's ST Score?
Jaguar Health, Inc. (JAGX) has an ST Score of 29.9 (C-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is JAGX a buy, hold, or sell?
Analysts rate JAGX a Buy, with a price target of $3.21 (+22.1% vs the current price). Our ST Score grades it C- (29.9/100). The ST Score is a data-driven signal, not a recommendation.
What are JAGX's factor grades?
Valuation C, Profitability C-, Financial Strength F, Momentum D, Growth B, Forecast D+.
What is JAGX's valuation grade?
Jaguar Health, Inc. (JAGX) earns a valuation grade of C, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is JAGX's growth grade?
Jaguar Health, Inc. (JAGX) earns a growth grade of B, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is JAGX's profitability grade?
Jaguar Health, Inc. (JAGX) earns a profitability grade of C-, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is JAGX's financial strength grade?
Jaguar Health, Inc. (JAGX) earns a financial strength grade of F, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for JAGX?
The average analyst price target for Jaguar Health, Inc. (JAGX) is $3.21 from 5 analysts, which is +22.1% versus the recent price of $2.63.
What is JAGX's Piotroski score?
Jaguar Health, Inc. (JAGX) has a Piotroski F-Score of 3 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.